CCK vs DDS
Crown Holdings vs Dillard's, Inc. — AI-powered side-by-side comparison
CCK
Crown Holdings
70
Buy
VS
DDS
Dillard's, Inc.
56
Watch
| Metric | CCK | DDS |
| AI Score |
70
|
56
|
| Price |
$119.98
|
$648.33
|
| P/E Ratio |
17.19×
|
15.36×
|
| ROE |
24.5%
|
32.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
17.5%
|
37.8%
|
| Debt / Equity |
2.19×
|
0.27×
|
| Dividend Yield |
1.1%
|
4.8%
|
| RSI (14) |
58.0
|
80.2
|
| Beta |
0.578
|
1.187
|
| Expected Upside |
+8.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for CCK versus DDS.
CCK leads by 14 points.
CCK scores 70/100 (Buy) versus DDS at 56/100 (Watch).
CCK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Weekly RSI at 77 -- overbought on the larger timeframe too — Technical
DDS Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -7.0% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 14.9 is inexpensive for the broad market — Value
- ROE of 33.8% shows genuine earnings power backing the valuation — Value
- Price structure making higher highs and higher lows — Technical
Bear Case
- Price-to-book of 5.6x prices in significant intangible value — Value
- Revenue declining -7.0% YoY -- this is not a growth story right now — Growth
- EPS declining -6.7% YoY despite any revenue growth — Growth